维普中文期刊产品整合服务
568篇 您的检索式:作者名="ROSENBERG SA"
    题名 作者 年代 出处 被引量
1白细胞介素2免疫治疗癌症的现状与展望显示文摘从带瘤宿主中分离的淋巴因子激活的杀伤(LAK)细胞,经体外培养于白细胞介素2(IL-2)进行选择扩增后可作为肿瘤特异性杀伤细胞。动物实验和临床试验表明,将这些非主要组织相容性(MHC)限制的杀伤细胞过继转移到带瘤宿主,可使所选患者的癌症消退。本文详述了作者进行的LAK细胞的治疗研究,并指出如何能够提高迄今所取得的临床效益。Rosenberg SA 俞慕华 1989国外医学(预防.诊断.治疗用生物制品分册)1989,12,1:3
2Perspectives on the role of surgery and radiation therapy in the treatment of soft tissue sarcomas of the extremities显示文摘Rosenberg SA Glatestein EJ 1981Semin Oncol1981,8,:1
3Results of treatment of 255 patients with metastatic renal cell carcinoma wtlo received high-dose recombinant interleukin-2 therapy 显示文摘Fyfe G Fisher RI Rosenberg SA 1995J Clin Oncol1995,13,3:1
4Experience with the use of high-dose interleukin-2 in the treatment of 65 cancer patients显示文摘Rosenberg SA Lotze MT Yang JC 1999Ann Surg1999,210,4:1
5Combination Immunotherapy for Cancer: Synergistic Antitumor Interactions of Interleukin-2, Alfa Interferon, and Tumor-Infiltrating Lymphocytes 显示文摘Rosenberg SA Schwarz SL Spiess PJ 1988J Natl Cancer nst1988,80,17:1
6Adoptive immunotherapy for cancer:harnessing the T cell response 显示文摘Restifo NP Dudley ME Rosenberg SA 2012Nat Rev Immunol2012,12,4:1
7Adoptive immu- notherapy for cancer: building on success 显示文摘Gattinoni L Powell DJ Jr Rosenberg SA 2006Nat Rev hnnmnol2006,6,5:1
8Cancer vaccines based on the identification of genes encoding cancer regression antigens显示文摘 1997Immunol Today1997,18,4:1
9Excitary amino acids as a final common pathway for neurological disorders显示文摘Lipton SA Rosenberg PA 1994N Engl J Med1994,330,9:1
10Adoptive im munotherapy for cancer: building on suceess显示文摘Gattiononi L Powell DJ Tr Rosenberg SA 2006Nat Rev Immu- nol2006,6,5:1
11Adoptive cell transfer as personalized immunotherapy for human cancer显示文摘Rosenberg SA Restifo NP 2015Science2015,348,6230:1
12Adoptive cell therapy for the treatment of patients with metastatic melanoma显示文摘Rosenberg SA Dudley ME 2009Curr Op in Immunol2009,21,2:1
13Excitatory amino acids as a final common pathway for neurologic disorders显示文摘Lipton SA Rosenberg PA 1994N Erlgl J Med1994,330,9:1
14Cell transfer therapy for cancer: Lessons from sequential treatments of a patient with metastatic melanoma 显示文摘Rosenberg SA Yang JC Robbins PF 2003J Immunother2003,26,5:1
15CD4 + CD25 + suppressor lymphocytes in the circulation of patients immunized against melanoma antigens显示文摘Javia LR Rosenberg SA 2003J Immunother2003,26,1:1
16Cancer immunotherapy: moving beyond current vaccines 显示文摘Rosenberg SA Yang JC Restifo NP 2004Nat Med2004,10,9:1
17Observations on the systemic administration of autologous lymphokine activated killer cells and recombinant interleukin-2 to patients with metastatic cancer显示文摘Rosenberg SA Lotze MT Muul LM 1985N Engl J Med1985,313,23:1
18Synthetic oligonucleotide expressed by a recombinant vaccinia virus elicits therapeutic CTL显示文摘 McCabe BJ Rosenberg SA 1995J Immunol1995,154,9:1
19A new approach to the adoptive immunotherapy of cancer with tumor-infiltrating lymphocyte显示文摘Rosenberg SA Spiess P Lafreniere R 1986Science1986,233,4770:1
20A new approach to the adoptive immunotherapy of cancer with tumor-infiltrating lym- phocytes显示文摘Rosenberg SA Spiess P Lafreniere R 1986Science1986,233,4770:1
返回顶部 每页显示:
共29页 首页 上一页 第1页 下一页 末页 /29 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费